Brock E.W. Turner’s Post

Hi Everyone! Matt, Brittany, and I have been so thrilled about the positive response to Health Bytes and we can’t wait to keep publishing new content. In this latest post, we took a look at what we expect to be in the forecast for healthcare investing, AI adoption, and health system evolution in 2024. At the end of this piece, we each made one final bold prediction that we will revisit in December to see just how right or wrong we were. Let us know what you think of our prognosis for 2024 in the comments and share your own predictions! If you’d like to see more of our content in the future, please join our 100+ subscribers! We predict that you will 😊 #HealthBytes #2024predictions #healthcare #investing #data #AI #healthsystems

New Era for #DigitalHealth Funding? Just read a fascinating article from Rock Health on Q1 2024 digital health #fundingtrends. Here are some key takeaways: ✔ We're seeing a shift towards smaller deals with higher volume, reflecting a more cautious funding environment. ✔ AI in healthcare is hotter than ever, attracting a growing share of investment. ✔ Investors are prioritizing companies that can demonstrate strong outcomes and sustainable business models. This is a positive development for the long-term health of the sector! ✔ Public digital health companies are facing delistings, which may influence future exit strategies for startups. The overall message? The digital health space is maturing. Companies need to focus on impactful solutions and responsible financial practices to thrive. What are your thoughts on these trends? Let's discuss in the comments! #healthcareinnovation #AI #funding https://lnkd.in/eN7ryhdr

In StartupWorld™, success is as much about what you don’t share as it is what you do – for example…. ➡️ DON’T share your unredacted investment deck with a competitor ➡️ DON’T comment on media speculation about your acquisition ➡️ DO wait until you’re at a conference to share your best advice to other founders (for maximum coverage) Pigeon knows this to be the case – (contrary to popular belief, there are things we don’t say out loud) – but we still believe that sharing = caring. So we find and share the best healthtech stories of the week, including…👇 👺 Digital therapeutics aren’t drugs, says DarioHealth ’s Omar Manejwala, M.D. ⏰ Times flies as Tempus AI files to go public, reports Heather Landi ䷰ Professor Sultan Mahmud incites a digital health revolution 🗣️ Katie Adams shares 4 investors’ deepest, darkest confessions (about digital health funding.) 🧫 Rebecca Torrence forces 13 mental health startups to refuse to comment on their acquisition, sale or IPO 🕶️ Benjamin Selaskowki et al challenge the quality of research into VR’s use in mental health 🤔 Some people think AI could save the NHS. Danny Fortson meets them. 🤖 Lea Goetz et al get very specific about generalisation in healthcare AI. Pods from… 🔊The Healthtech Pigeon Podcast with SomX’s Belle Taylor and Huw Penson 🔊The Healthtech Podcast with Dr. James Somauroo and Deloitte’s Sara Siegel 🔊UKTN | The Podcast with Inovus Medical’s Elliot Street Jobs & opps from… 📎  Lecturer in Computer Vision for Digital Health, University of Bristol 📎  Assistant Director of FDP Service Design, NHS England 📎  Head of Regulatory Affairs, Sano Genetics 📎  Experience Engineer, Current Health Read all the stories at healthtech pigeon dot com (link, as always, in comments) #digitalhealth #healthtechpigeon #mentalhealthtech #healthtech

The health tech industry — a $4T market — has all the necessary elements for a promising future: resilient founders, patient capital, and limitless opportunities for technical and business model innovation. In our first-ever State of Health Tech report, Sofia Guerra and Steve Kraus uncover trends from their quantitative and qualitative research, including recent market performance, benchmarks and best practices, and emerging predictions for 2024. Read it here: https://lnkd.in/gE2qJc9S

I agree with the authors that consumer empowerment, access to care (skrinking capacity of providers), gaps in care (specialization) and cost effectiveness to outcomes achieved is where the proverbial puck is heading. My experience with Bessemer back in 1997 is they are several steps ahead in the market. At that time they were part of a VC syndicate that backed a radiology services business focused on consolidation and integration. Sound familiar? Unfortunately our timing was way off and our execution fell way short. Fast forward 20 some years and now that market is maturing and hitting most if not all the cylinders. I personally believe that tech enabled companies focused on RPM, AI, cloud based combined with patient analytics will be in great demand very soon.

AI in digital health is not a "cure-all"—its true value shows best when its application is clearly defined and effectively enhances patient outcomes and healthcare provider efficiency. Digital health startups now need to be able to withstand scrutiny and gain the confidence of cautious investors. The ones prioritizing a strong value proposition backed by measurable clinical outcomes are coming out on top! #DigitalHealth #AI #Healthcare

Some positive signs in #digitalhealth funding so far in 2024. But, there's plenty of challenges for those in the space based on Rock Health's analysis. First the headlines: At this rate, 2024 funding could exceed 2023 levels of $10.7B. Mostly early stage deals, with the average deal size heavily skewed by a few massive Series A's: Zephyr AI $112 Million Allez Health $60 Million Fabric $60 Million (Median Series A size is 20% higher than 2023) AI-driven firms captured nearly 40% of the funds - is this a digital health story or an AI story? Mental health continues to be the most-invested condition for the 5th year running, while telehealth/on-demand health has plummeted on the value prop ranking side of things. Older firms (post-B) are going to struggle to get funding at this point, as Cheryl Cheng at Vive Collective points out: "The Series A pipeline is quite strong right now, and these early-stage rounds can feel like cleaner deals because they don’t have valuation overhangs.” Exits are starting to look a little more promising, with 3 IPOs this year (Nuvo Cares, Waystar, and Tempus AI) and amazingly, several PE purchases. The most likely buyers of digital health companies are...other digital health companies. Though as Joanna Strober from Midi Health points out: “There are many good companies trying to get bought, but it’s hard to make those deals work. Even if they are interesting companies, potential buyers are focused on their immediate priorities. Anything that is not directly related to what we are trying to get done is de-focusing and incredibly risky.” All this to say, it's a mixed bag - in short: - Good to be an early stage AI-driven Mental Health Startup - Less good to be a later stage company - Valuations still have a way to go before rationalizing for some previously funded digital health companies. What would you add? Drop a comment  https://lnkd.in/gF8PFs8E

I predict venture capital in the digital health sector to continue facing significant losses in 2024. This trend is due to a lack of due diligence and competence within the #venturecapital community. The #digitalhealth industry has already seen substantial failures in 2023 (https://lnkd.in/e6SJXdzs) with companies like Babylon Health, Olive AI, and Bright Healthcare, which resulted in billions in financial losses for investors. The pattern of investing in startups run by bullshit “visionaries” is expected to persist. VCs have a short-term memory. This one was the easiest prediction to make. Which of my seven 2024 digital health predictions do I believe will have the most significant impact on the digital health industry? Check out my latest deep dive into the 2024 digital health competitive landscape, "Digital Health 2024: 7 Predictions & 50 Names You Don’t Want to Miss": https://lnkd.in/erNTVcte.

💡 Great read 📑 Health Tech - Where are we going? Emerging 2024 predictions Prediction 1. AI gives rise to Services-as-Software Prediction 2. Healthcare payments companies win by aligning incentives Prediction 3. Health tech businesses leverage indirect monetization for a distribution advantage Prediction 4. Startups focus on making the biopharma value chain more efficient I am particularly drawn to # 4 where I'd love to hear Sofia Guerra and Steve Kraus perspective about shortening the value chain to accelerate personalized medicine. #healthtechinnovation #precisionmedicine #personalizedmedicine #startup

By focusing on bridging gaps in health & wealth, Sydney Paige Thomas (KF26) and Symphonic Capital exemplify how #VC can be a force for societal good. Listen in: https://lnkd.in/gWnakczX 🩺 Navigating the Shift to Value-Based Healthcare 🎯 The Critical Role of Diverse Data in AI Development